Damon Runyon Cancer Research Foundation

Whether you are a reporter, journalist or producer, the Damon Runyon Cancer Research Foundation can provide expert commentary on a number of topics, from the challenges facing young researchers to new trends in cancer research. Damon Runyon can also provide introductions to bright, articulate scientists and doctors in positions of authority at institutions across the country. > Learn More

Press Contact Information:

Todd Brogan at 212.455.0552 or todd.brogan@damonrunyon.org
Communications Coordinator
Damon Runyon Cancer Research Foundation

Bryant Hilton at 202.347.7947 or bhilton@theheraldgroup.com
Media Contact
The Herald Group

RELEASES:

March 5, 2012: Industry Leaders Join Together for Accelerating Cancer Cures Research Symposium

June 21, 2011: Leaders in Fight Against Cancer Join Historic Initiative to Address Critical Shortage of Clinical Investigators

MENTIONS:

August 28, 2011: William L. Carroll, MD, Director of the NYU Cancer Institute, interviews Damon Runyon Clinical Investigators Zsofia K. Stadler, MD, and Rachael A. Clark, MD, PhD on SiriusXM's Doctor Radio Reports

July 20, 2011: Patrick A. Brown, MD, Assistant Professor of Oncology and Pediatrics at The Johns Hopkins Hospital, discusses his work as a clinical investigator on SiriusXM's Doctor Radio

July 8, 2011: Pharma consortium aims to rectify shortage of cancer researchers in Boston Business Journal

July 6, 2011: Lilly Joins National Cancer Campaign on Inside Indiana Business

June 23, 2011: Cancer foundation selects UT Southwestern professor as fund recipient in Dallas Morning News

June 23, 2011: Accelerating Cancer Cures initiative tackles clinical investigator gap on PharmaTimes Online

June 22, 2011: Damon Runyon Establishes New Fund to Support Clinical Investigators on Philanthropy News Digest

June 21, 2011: Battling Cancer: We’re All in This Together on LillyPad

June 21, 2011: Novel Industry and Philanthropy Collaboration to Accelerate Cancer Cures on The Catalyst

June 21, 2011: Daily News Digest on FiercePharma

About Accelerating Cancer Cures

Accelerating Cancer Cures addresses the critical shortage of new clinical researchers working on breakthroughs in cancer treatments and cures. Under the leadership of the Damon Runyon Cancer Research Foundation and with the support of industry and academia, this project will foster the talent desperately needed to accelerate breakthroughs in cancer prevention, diagnosis and treatment. Accelerating Cancer Cures is supported by some of the world’s leading companies including: Eli Lilly and Company, Celgene, Merck, Millennium: The Takeda Oncology Company, Pfizer, and The Pharmaceutical Research and Manufacturers of America (PhRMA). For more information, visit www.damonrunyon.org/accelerate.

About the Damon Runyon Cancer Research Foundation

To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative research. Eleven scientists supported by the Foundation have received the Nobel Prize, seven have received National Medals of Science, and 61 have been elected to the National Academy of Sciences. Damon Runyon is currently funding more than 100 scientists at leading medical centers and research institutions.

Since its founding in 1946, Damon Runyon has invested more than $245 million and funded more than 3,300 young scientists. This year, it will commit approximately $12 million in new awards to brilliant young investigators. 100% of all donations to the Foundation are used to support cutting-edge scientific research. Its administrative and fundraising costs are paid from Damon Runyon Broadway Tickets and an endowment. For more information, visit www.damonrunyon.org.